OA11674A
(en)
*
|
1998-11-10 |
2005-01-12 |
Janssen Pharmaceutica Nv |
HIV Replication inhibiting pyrimidines.
|
GB9914258D0
(en)
*
|
1999-06-18 |
1999-08-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
DE19945982A1
(de)
*
|
1999-09-24 |
2001-03-29 |
Knoll Ag |
Geschwindigkeitsbestimmte Partikel
|
EA005423B1
(ru)
*
|
1999-09-24 |
2005-02-24 |
Янссен Фармацевтика Н.В. |
Противовирусные композиции
|
JP2003511378A
(ja)
|
1999-10-07 |
2003-03-25 |
アムジエン・インコーポレーテツド |
トリアジン系キナーゼ阻害薬
|
WO2001060816A1
(en)
|
2000-02-17 |
2001-08-23 |
Amgen Inc. |
Kinase inhibitors
|
ES2542326T3
(es)
*
|
2000-05-08 |
2015-08-04 |
Janssen Pharmaceutica Nv |
Inhibidores de la replicación del VIH
|
DK1282607T3
(en)
*
|
2000-05-08 |
2016-02-01 |
Janssen Pharmaceutica Nv |
Prodrugs of HIV replication inhibiting pyrimidines
|
EP1337931A4
(en)
*
|
2000-11-01 |
2005-05-11 |
Snapnames Com Inc |
DOMAIN NAME ACQUISITION AND MANAGEMENT SYSTEM AND METHOD
|
US6958211B2
(en)
|
2001-08-08 |
2005-10-25 |
Tibotech Bvba |
Methods of assessing HIV integrase inhibitor therapy
|
US8101629B2
(en)
|
2001-08-13 |
2012-01-24 |
Janssen Pharmaceutica N.V. |
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
US7638522B2
(en)
|
2001-08-13 |
2009-12-29 |
Janssen Pharmaceutica N.V. |
Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
EP2090571B1
(de)
*
|
2001-10-17 |
2012-05-16 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Pyrimidinderivate, Arzneimittel enthaltend diese Verbindungen, deren Verwendung und Verfahren zu ihrer Herstellung
|
EP1453516A2
(de)
|
2001-10-17 |
2004-09-08 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
5-substituierte 4-amino-2-phenylamino-pyrimdinderivate und ihre verwendung als beta-amyloid modulatoren
|
US7183288B2
(en)
|
2001-11-01 |
2007-02-27 |
Herwig Josephus Margareta Janssen, legal representative |
Amide derivatives as glycogen synthase kinase 3-β inhibitors
|
EP1448556A1
(en)
|
2001-11-01 |
2004-08-25 |
Janssen Pharmaceutica N.V. |
Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
|
SE0104140D0
(sv)
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
TWI329105B
(en)
*
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
PL212089B1
(pl)
|
2002-03-13 |
2012-08-31 |
Janssen Pharmaceutica Nv |
Związki heterocykliczne jako inhibitory deacetylazy histonowej, kompozycja farmaceutyczna je zawierająca, ich zastosowanie, sposób wytwarzania, sposób wykrywania lub identyfikacji HDAC oraz kompozycja
|
KR20040094672A
(ko)
|
2002-03-13 |
2004-11-10 |
얀센 파마슈티카 엔.브이. |
히스톤 디아세틸라제의 신규한 저해제로서의설포닐아미노-유도체
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
WO2003093344A1
(en)
*
|
2002-05-03 |
2003-11-13 |
Janssen Pharmaceutica N.V. |
Polymeric microemulsions
|
AR039540A1
(es)
*
|
2002-05-13 |
2005-02-23 |
Tibotec Pharm Ltd |
Compuestos microbicidas con contenido de pirimidina o triazina
|
AR040456A1
(es)
|
2002-06-27 |
2005-04-06 |
Bristol Myers Squibb Co |
Piridina n-oxidos 2,4 -disubstituidos utiles como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana
|
US7517886B2
(en)
|
2002-07-29 |
2009-04-14 |
Rigel Pharmaceuticals, Inc. |
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
|
CN101481356B
(zh)
*
|
2002-08-09 |
2012-07-11 |
詹森药业有限公司 |
制备4-[[4-[[4-(2-氰基乙烯基)-2,6-二甲基苯基]氨基]-2-嘧啶基]氨基]苄腈的方法
|
DK1551372T3
(en)
*
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
|
EA200500721A1
(ru)
*
|
2002-11-28 |
2005-12-29 |
Шеринг Акциенгезельшафт |
Пиримидины, ингибирующие chk, pdk и акт, их получение и применение в качестве лекарственных средств
|
EP1599468B1
(en)
|
2003-01-14 |
2007-10-03 |
Arena Pharmaceuticals, Inc. |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
MXPA05008368A
(es)
*
|
2003-02-07 |
2005-11-04 |
Janssen Pharmaceutica Nv |
1,2,4-triazinas inhibidoras del virus de inmunodeficiencia humana.
|
EP1597237B1
(en)
|
2003-02-07 |
2016-07-27 |
Janssen Pharmaceutica NV |
Pyrimidine derivatives for the prevention of HIV infection
|
CL2004000303A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
|
ES2325440T3
(es)
|
2003-02-20 |
2009-09-04 |
Smithkline Beecham Corporation |
Compuestos de pirimidina.
|
WO2005011702A1
(en)
*
|
2003-07-17 |
2005-02-10 |
Tibotec Pharmaceuticals Ltd. |
Process for preparing particles containing an antiviral
|
CN102358738A
(zh)
|
2003-07-30 |
2012-02-22 |
里格尔药品股份有限公司 |
2,4-嘧啶二胺化合物及其预防和治疗自体免疫疾病的用途
|
WO2005028479A2
(en)
*
|
2003-09-25 |
2005-03-31 |
Janssen Pharmaceutica N.V. |
Hiv replication inhibiting purine derivatives
|
EP1728186A2
(en)
|
2004-03-02 |
2006-12-06 |
Virco Bvba |
Estimation of clinical cut-offs
|
EP1598343A1
(de)
*
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
2-Arylaminopyrimidine als PLK Inhibitoren
|
WO2006010750A1
(en)
|
2004-07-28 |
2006-02-02 |
Janssen Pharmaceutica N.V. |
Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
|
RU2401833C2
(ru)
|
2004-08-10 |
2010-10-20 |
Янссен Фармацевтика Н.В. |
Производные 1, 2, 4-триазин-6-она, ингибирующие вич
|
TW200626574A
(en)
*
|
2004-09-30 |
2006-08-01 |
Tibotec Pharm Ltd |
HIV inhibiting 5-heterocyclyl pyrimidines
|
CN101027288B
(zh)
*
|
2004-09-30 |
2013-04-17 |
泰博特克药品有限公司 |
抑制hiv的5-取代嘧啶
|
BRPI0515935B8
(pt)
|
2004-09-30 |
2021-05-25 |
Janssen Sciences Ireland Uc |
pirimidinas heterociclil- ou 5-carbo substituídas para inibição de hiv, e composição farmacêutica
|
BRPI0517272A
(pt)
|
2004-10-29 |
2008-10-07 |
Tibotec Pharm Ltd |
derivados de pirimidina bicìclicos de inibição de hiv
|
CA2583187A1
(en)
*
|
2004-11-08 |
2006-05-18 |
Boehringer Ingelheim International Gmbh |
Method for treating hiv infection through co-administration of tipranavir and etravirine
|
CA2584295C
(en)
|
2004-11-24 |
2014-08-26 |
Rigel Pharmaceuticals, Inc. |
Spiro-2, 4-pyrimidinediamine compounds and their uses
|
DE602006010979D1
(de)
|
2005-01-19 |
2010-01-21 |
Rigel Pharmaceuticals Inc |
Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
|
AU2006208778B2
(en)
|
2005-01-27 |
2012-08-09 |
Janssen Sciences Ireland Uc |
HIV inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives
|
WO2006087530A1
(en)
|
2005-02-16 |
2006-08-24 |
Astrazeneca Ab |
Chemical compounds
|
JP5247154B2
(ja)
*
|
2005-02-18 |
2013-07-24 |
テイボテク・フアーマシユーチカルズ |
Hiv阻害性2−(4−シアノフェニルアミノ)ピリミジンオキシド誘導体
|
RU2401261C2
(ru)
*
|
2005-03-04 |
2010-10-10 |
Тиботек Фармасьютикалз Лтд. |
Ингибирующие вич 2-(4-цианофенил)-6-гидроксиламинопиримидины
|
EP1899323A2
(en)
|
2005-05-16 |
2008-03-19 |
AstraZeneca AB |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
MX2007014881A
(es)
*
|
2005-05-26 |
2008-02-15 |
Tibotec Pharm Ltd |
Procedimiento para preparar 4-(1,6-dihidro-6-oxo-2-pirimidinil) amino benzonitrilo.
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
WO2006133426A2
(en)
|
2005-06-08 |
2006-12-14 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
US7754773B2
(en)
*
|
2005-10-06 |
2010-07-13 |
University Of Massachusetts |
Composition and synthesis of new reagents for inhibition of HIV replication
|
BRPI0618011A2
(pt)
|
2005-10-28 |
2011-08-16 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito anti-proliferativo e um efeito pró-apoptósico em um animal de sangue quente, para tratar doença e para produzir um efeito inibidor de jak em um animal de sangue quente
|
EP1979326B1
(en)
|
2006-01-19 |
2012-10-03 |
Janssen Pharmaceutica N.V. |
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
|
AU2007206950B2
(en)
|
2006-01-19 |
2012-02-02 |
Janssen Pharmaceutica N.V. |
Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
|
DK1981874T3
(da)
|
2006-01-19 |
2009-09-28 |
Janssen Pharmactuica N V |
Aminophenylderivater som nye inhibitorer af histondeacetylase
|
CA2642229C
(en)
|
2006-02-24 |
2015-05-12 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
EP2004632B1
(en)
|
2006-03-30 |
2014-03-12 |
Janssen R&D Ireland |
Hiv inhibiting 5-amido substituted pyrimidines
|
EP2004641B1
(en)
|
2006-03-30 |
2010-09-29 |
Tibotec Pharmaceuticals |
Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
|
PE20080068A1
(es)
|
2006-05-15 |
2008-03-17 |
Boehringer Ingelheim Int |
Compuestos derivados de pirimidina como inhibidores de la quinasa aurora
|
WO2007141308A1
(en)
*
|
2006-06-06 |
2007-12-13 |
Tibotec Pharmaceuticals Ltd. |
Process for preparing spray dried formulations of tmc125
|
CN101677963B
(zh)
|
2006-06-19 |
2012-05-30 |
奥尔制药公司 |
药物组合物
|
CA2665726C
(en)
*
|
2006-10-11 |
2016-04-19 |
Alpharma, Inc. |
Pharmaceutical compositions
|
EP2104491B1
(en)
|
2006-12-06 |
2017-02-22 |
Janssen Sciences Ireland UC |
Hydrobromide salt of an anti-hiv compound
|
AU2007341228B2
(en)
|
2006-12-29 |
2013-04-18 |
Janssen Sciences Ireland Uc |
HIV inhibiting 5,6-substituted pyrimidines
|
CA2674178C
(en)
|
2006-12-29 |
2015-11-10 |
Tibotec Pharmaceuticals Ltd. |
Hiv inhibiting 6-substituted pyrimidines
|
UA99459C2
(en)
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
EP2212298B1
(en)
*
|
2007-10-18 |
2013-03-27 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US20090196890A1
(en)
*
|
2007-12-17 |
2009-08-06 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical compositions
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
CA2723961C
(en)
|
2008-05-21 |
2017-03-21 |
Ariad Pharmaceuticals, Inc. |
Phosphorous derivatives as kinase inhibitors
|
BRPI0914682B8
(pt)
|
2008-06-27 |
2021-05-25 |
Avila Therapeutics Inc |
compostos de heteroarila e composições compreendendo os referidos compostos
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
TW201016676A
(en)
*
|
2008-10-03 |
2010-05-01 |
Astrazeneca Ab |
Heterocyclic derivatives and methods of use thereof
|
US20110071158A1
(en)
*
|
2009-03-18 |
2011-03-24 |
Boehringer Ingelheim International Gmbh |
New compounds
|
CN102369009B
(zh)
|
2009-03-30 |
2014-04-30 |
泰博特克药品公司 |
依曲韦林和烟酰胺的共晶体
|
CN102482277B
(zh)
|
2009-05-05 |
2017-09-19 |
达纳-法伯癌症研究所有限公司 |
表皮生长因子受体抑制剂及治疗障碍的方法
|
WO2010131118A2
(en)
*
|
2009-05-12 |
2010-11-18 |
Pliva Hrvatska D.O.O. |
Polymorphs of etravirine and processes for preparation thereof
|
EP2342186B1
(en)
|
2009-06-22 |
2014-09-17 |
Emcure Pharmaceuticals Limited |
Process for synthesis of etravirine
|
US8153790B2
(en)
|
2009-07-27 |
2012-04-10 |
Krizmanic Irena |
Process for the preparation and purification of etravirine and intermediates thereof
|
GR1007010B
(el)
|
2009-10-08 |
2010-10-07 |
Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), |
Ινσουλινοειδη πεπτιδια
|
CA2797947C
(en)
|
2010-06-04 |
2019-07-09 |
Charles Baker-Glenn |
Aminopyrimidine derivatives as lrrk2 modulators
|
WO2012001695A1
(en)
|
2010-06-28 |
2012-01-05 |
Hetero Research Foundation |
A process for etra virine intermediate and polymorphs of etravirine
|
KR20130099040A
(ko)
|
2010-08-10 |
2013-09-05 |
셀진 아빌로믹스 리서치, 인코포레이티드 |
Btk 억제제의 베실레이트 염
|
AU2011305525B2
(en)
|
2010-09-22 |
2016-08-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the GPR119 receptor and the treatment of disorders related thereto
|
BR112013010564B1
(pt)
|
2010-11-01 |
2021-09-21 |
Celgene Car Llc |
Compostos heterocíclicos e composições compreendendo os mesmos
|
JP5956999B2
(ja)
|
2010-11-01 |
2016-07-27 |
セルジーン アヴィロミクス リサーチ, インコーポレイテッド |
ヘテロアリール化合物およびその使用
|
ES2665013T3
(es)
|
2010-11-10 |
2018-04-24 |
Celgene Car Llc |
Inhibidores de EGFR selectivos de mutante y usos de los mismos
|
HUE046617T2
(hu)
|
2010-11-10 |
2020-03-30 |
Genentech Inc |
Pirazol-aminopirimidin-származékok mint LRRK2 modulátorok
|
PL2702045T3
(pl)
|
2011-04-26 |
2018-04-30 |
Mylan Laboratories Ltd. |
Nowy sposób sporządzania Etrawiryny
|
CN103501612B
(zh)
|
2011-05-04 |
2017-03-29 |
阿里亚德医药股份有限公司 |
抑制表皮生长因子受体导致的癌症中细胞增殖的化合物
|
WO2012170647A1
(en)
*
|
2011-06-09 |
2012-12-13 |
Assia Chemical Industriew Ltd. |
Process for the preparation of etravirine and intermediates in the synthesis thereof
|
ES2690971T3
(es)
|
2011-08-23 |
2018-11-23 |
Asana Biosciences, Llc |
Compuestos pirimido-piridazinona y uso de los mismos
|
WO2013059572A1
(en)
|
2011-10-19 |
2013-04-25 |
Assia Chemical Industries Ltd. |
Process for the preparation of etravirine and intermediates in the synthesis thereof
|
US9364476B2
(en)
|
2011-10-28 |
2016-06-14 |
Celgene Avilomics Research, Inc. |
Methods of treating a Bruton's Tyrosine Kinase disease or disorder
|
WO2013109354A2
(en)
*
|
2011-12-07 |
2013-07-25 |
Texas Southern University |
Etravirine formulations and uses thereof
|
EP2825042B1
(en)
|
2012-03-15 |
2018-08-01 |
Celgene CAR LLC |
Salts of an epidermal growth factor receptor kinase inhibitor
|
BR112014022789B1
(pt)
|
2012-03-15 |
2022-04-19 |
Celgene Car Llc |
Formas sólidas de um inibidor de quinase de receptor do fator de crescimento epidérmico, composição farmacêutica e usos do mesmo
|
WO2013169401A1
(en)
|
2012-05-05 |
2013-11-14 |
Ariad Pharmaceuticals, Inc. |
Compounds for inhibiting cell proliferation in egfr-driven cancers
|
US20150336900A1
(en)
*
|
2012-10-29 |
2015-11-26 |
Biophore India Pharmaceuticals Pvt. Ltd. |
Process for the Synthesis of Etravirine and Its Intermediates
|
WO2014072419A1
(en)
|
2012-11-08 |
2014-05-15 |
Universiteit Antwerpen |
Novel anti-hiv compounds
|
WO2014100748A1
(en)
|
2012-12-21 |
2014-06-26 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
MX2015007945A
(es)
|
2012-12-21 |
2016-02-16 |
Verlyx Pharma Inc |
Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas.
|
US9145387B2
(en)
|
2013-02-08 |
2015-09-29 |
Celgene Avilomics Research, Inc. |
ERK inhibitors and uses thereof
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
US9415049B2
(en)
|
2013-12-20 |
2016-08-16 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
US10005760B2
(en)
|
2014-08-13 |
2018-06-26 |
Celgene Car Llc |
Forms and compositions of an ERK inhibitor
|
CN116850181A
(zh)
|
2015-01-06 |
2023-10-10 |
艾尼纳制药公司 |
治疗与s1p1受体有关的病症的方法
|
CN104926829A
(zh)
*
|
2015-06-08 |
2015-09-23 |
山东大学 |
一种噻吩并嘧啶类衍生物及其制备方法和应用
|
ES2929526T3
(es)
|
2015-06-22 |
2022-11-29 |
Arena Pharm Inc |
Sal cristalina de L-arginina del ácido (R)-2-(7-(4-ciclopentil-3-(trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para su uso en trastornos asociados al receptor S1P1
|
CN110066273A
(zh)
*
|
2019-06-05 |
2019-07-30 |
山东大学 |
一种含三氮唑环的单芳基嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用
|
WO2021003417A1
(en)
|
2019-07-03 |
2021-01-07 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Tyrosine kinase non-receptor 1 (tnk1) inhibitors and uses thereof
|
CN111217833B
(zh)
*
|
2020-02-21 |
2021-03-16 |
山东大学 |
噻吩并[2,3-d]嘧啶类HIV-1非核苷类逆转录酶抑制剂及其制备方法和应用
|
CN111875548A
(zh)
*
|
2020-07-16 |
2020-11-03 |
山东大学 |
一种5位芳环取代的二芳基嘧啶类衍生物及其制备方法与应用
|